Suppr超能文献

确定妊娠和哺乳期相关骨质疏松症的风险因素:来自意大利一项针对妊娠和哺乳期相关骨质疏松症患者及对照的调查的见解。

Identifying risk factors for pregnancy and lactation-associated osteoporosis: insights from an Italian survey in PLAO patients and controls.

作者信息

Grassi Giorgia, Zampogna Marta, Atlasova Anna, Rondinella Sara, Ghielmetti Alberto, Siracusano Giordana, Chiodini Iacopo, Mantovani Giovanna, Eller-Vainicher Cristina

机构信息

Endocrine Unit, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.

Department of Clinical Sciences and Community Health, Dipartimento di Eccellenza 2023-2027, University of Milan, Milan, Italy.

出版信息

Front Endocrinol (Lausanne). 2025 Jul 22;16:1612188. doi: 10.3389/fendo.2025.1612188. eCollection 2025.

Abstract

BACKGROUND

Pregnancy and lactation-associated osteoporosis (PLAO) is characterized by fragility fractures during late pregnancy and postpartum period. The risk factors for PLAO are largely unknown. This study aims to identify the risk factors for PLAO, related and unrelated to pregnancy.

PATIENTS AND METHODS

A questionnaire on clinical history, lifestyle factors, nutritional habits, and pregnancy-related characteristics was administered to 155 women with PLAO and 182 women without PLAO.

RESULTS

Women with PLAO were older (32.9 ± 4.7 years), showed a higher prevalence of BMI <18.5 Kg/m2 (23.6%), eating disorders (11.6%), amenorrhea (7.1%), chronic diseases associated with bone fragility (11.7%), calcium-intake <500 mg/day (66.9%), previous fragility fractures (18.7%), blue sclerae (5.2%) and family history of vertebral/femoral FXs (21.0%) than women without PLAO (31.6 ± 5.4 years, 13.8%, 5.5%, 2.2%, 2.6%, 50.8%, 6.0%, 0.5%, 11.0%, p<0.05 for all comparisons). The risk of PLAO was associated with pre-pregnancy fragility fractures (odds ratio, OR 2.7, 95% Confidence Interval, CI, 1.199-6.036, p=0.016), chronic diseases (OR 5.8 95% CI, 1.919-17.562, p=0.002), age at pregnancy (OR 1.1, 95% CI, 1.005-1.109, p=0.030), BMI<18.5 Kg/m (OR 2.0, 95% CI, 1.042-3.902, p=0.037) and calcium-intake <500 mg/day (OR 2.5 95% CI, 1.485-4.166, p=0.01). During pregnancy, PLAO women showed a higher prevalence of insufficient weight gain (49.0%), calcium-intake <500 mg/day (67.1%), history of bed rest (21.9%) and use of low-molecular-weight heparin (LMWH, 25.2%). An increased risk of PLAO was associated with calcium intake <500 mg/day during pregnancy (OR 1.5, 95% CI, 1.047-2.141, p=0.027), insufficient weight gain (OR 1.8, 95% CI, 1.109-3.003 p=0.018) and LMWH use (OR 2.0, 95% CI, 1.124-3.682, p=0.019).

CONCLUSIONS

PLAO, a condition with relevant impact on women's health, is associated with BMI <18.5, low calcium intake, age at pregnancy, previous fragility fractures and the presence of chronic diseases before pregnancy and with insufficient weight gain, LMWH use and low calcium intake during pregnancy.

摘要

背景

妊娠和哺乳期骨质疏松症(PLAO)的特征是在妊娠晚期和产后出现脆性骨折。PLAO的危险因素大多未知。本研究旨在确定PLAO与妊娠相关和不相关的危险因素。

患者与方法

对155例PLAO女性和182例非PLAO女性进行了关于临床病史、生活方式因素、营养习惯和妊娠相关特征的问卷调查。

结果

PLAO女性年龄较大(32.9±4.7岁),体重指数(BMI)<18.5 Kg/m²的患病率较高(23.6%)、饮食失调(11.6%)、闭经(7.1%)、与骨脆性相关的慢性病(11.7%)、钙摄入量<500毫克/天(66.9%)、既往脆性骨折(18.7%)、蓝色巩膜(5.2%)以及椎体/股骨骨折的家族史(21.0%),均高于非PLAO女性(31.6±5.4岁、13.8%、5.5%、2.2%、2.6%、50.8%、6.0%、0.5%、11.0%,所有比较p<0.05)。PLAO的风险与孕前脆性骨折(比值比,OR 2.7,95%置信区间,CI,1.199 - 6.036,p = 0.016)、慢性病(OR 5.8,95% CI,1.919 - 17.562,p = 0.002)、妊娠年龄(OR 1.1,95% CI,1.005 - 1.109,p = 0.030)、BMI<18.5 Kg/m(OR 2.0,95% CI,1.042 - 3.902,p = 0.037)以及钙摄入量<500毫克/天(OR 2.5,95% CI,1.485 - 4.166,p = 0.01)相关。在妊娠期间,PLAO女性体重增加不足(49.0%)、钙摄入量<500毫克/天(67.1%)、卧床休息史(21.9%)和使用低分子量肝素(LMWH,25.2%)的患病率较高。PLAO风险增加与妊娠期间钙摄入量<500毫克/天(OR 1.5,95% CI,1.047 - 2.141,p = 0.027)、体重增加不足(OR 1.8,95% CI,1.109 - 3.003,p = 0.018)和LMWH使用(OR 2.0,95% CI,1.124 - 3.682,p = 0.019)相关。

结论

PLAO对女性健康有重大影响,与BMI<18.5、钙摄入量低、妊娠年龄、既往脆性骨折以及孕前存在慢性病有关,还与妊娠期间体重增加不足、LMWH使用和钙摄入量低有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9515/12322702/5d4009a9019f/fendo-16-1612188-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验